Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
159.6 USD | -2.04% | -2.55% | +2.99% |
22/05 | Strides Pharma Arm Gets US FDA's Approval for Generic Stomach Ulcer Drug | MT |
17/05 | Cantor Fitzgerald Initiates AbbVie at Overweight Rating With $200 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.99% | 282B | |
+37.74% | 723B | |
+34.64% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+16.89% | 244B | |
+10.02% | 208B | |
-4.42% | 205B | |
+7.43% | 166B | |
+2.81% | 168B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Societe Generale Upgrades AbbVie to Buy from Hold, Raises Price Target to $172 From $111